TY  - JOUR

T1  - Erratum to: ‘Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial

JO  - Trials

UR  - http://eprints.whiterose.ac.uk/97850/

PY  - 2016/02/03

AU  - Yardley DA

AU  - Brufsky A

AU  - Coleman RE

AU  - Conte PF

AU  - Cortes J

AU  - Glück S

AU  - Nabholtz J-MA

AU  - O’Shaughnessy J

AU  - Beck RM

AU  - Ko A

AU  - Renschler MF et al

ED  - 

DO  - DOI: 10.1186/s13063-016-1195-6

VL  - 17

IS  - 1

Y2  - 2025/10/10

ER  -